Denali Therapeutics Inc. (DNLI) Net margin 2018–2023
Denali Therapeutics Inc. (DNLI) net profit margin by fiscal year — reported net income divided by reported revenue.
-43.9%FY2023 · since FY2018: -28.1% → -43.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -43.9% | +266.3 pp |
| FY2022 | -310.3% | +286.9 pp |
| FY2021 | -597.2% | -618.4 pp |
| FY2020 | 21.2% | +772.0 pp |
| FY2019 | -750.8% | -722.7 pp |
| FY2018 | -28.1% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice